Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Pain Related to Cancer × Methadone × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Pain 10 Neoplasms 7 Cancer Pain 5 Pain, Postoperative 2 Pain, Intractable 2 Leukemia 2 Waldenstrom Macroglobulinemia 1 Vomiting 1 Urinary Bladder Neoplasms 1 Thrombocythemia, Essential 1 Stage III Cutaneous Squamous Cell Carcinoma of the Head and Neck AJCC v8 1 Spinal Surgery 1 Sleep Wake Disorders 1 Signs and Symptoms 1 Sezary Syndrome 1 Rectal Neoplasms 1 Primary Myelofibrosis 1 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Precancerous Conditions 1 Postoperative Complications 1 Polycythemia Vera 1 Pdgfra-Associated Chronic Eosinophilic Leukemia 1 Pathologic Processes 1 Pain Related to Cancer 1 Neurologic Manifestations 1 Neoplasms, Plasma Cell 1 Nausea 1 Myeloproliferative Disorders 1 Myelodysplastic-Myeloproliferative Diseases 1

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01793480 2024-10-31

EQUIMETH2

RECORDATI GROUP

Phase 3 Completed

Pain Related to Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡